Prasugrel - CISMeF

Preferred Label : Prasugrel;

NCIt definition : An orally bioavailable thienopyridine, with antiplatelet activity. Upon oral administration, the active metabolite of prasugrel targets and irreversibly binds to the platelet receptor for adenosine diphosphate (ADP), thereby blocking the binding of ADP to its receptor. This inhibits ADP-mediated activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation. This results in increased bleeding time.;

UNII : 34K66TBT99;

InChIKey : DTGLZDAWLRGWQN-UHFFFAOYSA-N;

CAS number : 150322-43-3;

Chemical formula : C20H20FNO3S;

Codes from synonyms : 415;

Details

Origin ID

C81566;

UMLS CUI

C1620287;

Automatic exact mappings (from CISMeF team)
- Prasugrel Hydrochloride [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Prasugrel [Substance BNPC]
- Prasugrel (substance) [SNOMED CT concept]
- Product containing prasugrel (medicinal product) [SNOMED CT concept]
- prasugrel [ATC Code]
- prasugrel [MeSH concept]
Validated automatic mappings to BTNT
- prasugrel [ATC Code]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]
has_salt_form
- Prasugrel Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Prasugrel Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients